115 related articles for article (PubMed ID: 3040340)
1. Effects of pirazolac on arachidonic acid metabolism in the human synovial system.
Kurowski M; Dunky A; Geddawi M
Curr Med Res Opin; 1987; 10(7):494-501. PubMed ID: 3040340
[TBL] [Abstract][Full Text] [Related]
2. Sodium naproxen: concentration and effect on inflammatory response mediators in human rheumatoid synovial fluid.
Bertin P; Lapicque F; Payan E; Rigaud M; Bailleul F; Jaeger S; Treves R; Netter P
Eur J Clin Pharmacol; 1994; 46(1):3-7. PubMed ID: 8005184
[TBL] [Abstract][Full Text] [Related]
3. [Leukotriene B4, leukotriene C4 and prostaglandin E2 in the serum, synovial fluid and synovium in patients with rheumatoid arthritis].
Sawazaki Y
Nihon Ika Daigaku Zasshi; 1989 Dec; 56(6):559-64. PubMed ID: 2558123
[TBL] [Abstract][Full Text] [Related]
4. Transsynovial distribution and protein binding of pirazolac in patients with rheumatoid arthritis.
Kurowski M; Dunky A; Geddawi M
Eur J Clin Pharmacol; 1986; 31(3):307-11. PubMed ID: 3792428
[TBL] [Abstract][Full Text] [Related]
5. Reduction of prostaglandin E2 concentrations in synovial fluid of patients suffering from rheumatoid arthritis following tiaprofenic acid or indomethacin treatment.
Daymond TJ; Rowell FJ
Drugs; 1988; 35 Suppl 1():4-8. PubMed ID: 3162870
[TBL] [Abstract][Full Text] [Related]
6. 15-Hydroxy-eicosatetraenoic acid (15-HETE) inhibits carrageenan-induced experimental arthritis and reduces synovial fluid leukotriene B4 (LTB4).
Fogh K; Hansen ES; Herlin T; Knudsen V; Henriksen TB; Ewald H; Bünger C; Kragballe K
Prostaglandins; 1989 Feb; 37(2):213-28. PubMed ID: 2543035
[TBL] [Abstract][Full Text] [Related]
7. Effects of non-steroidal anti-inflammatory drugs and prednisolone on synovial fluid white cells, prostaglandin E2, leukotriene B4 and cyclic AMP in patients with rheumatoid arthritis.
Seppälä E; Nissilä M; Isomäki H; Wuorela H; Vapaatalo H
Scand J Rheumatol; 1990; 19(1):71-5. PubMed ID: 2155476
[TBL] [Abstract][Full Text] [Related]
8. Neutrophil functional and arachidonic acid metabolic correlates and clinical disease activity in pirazolac-treated rheumatoid arthritis patients.
Turner RA; Johnson JA; Turner SR; McGee M; Kashanian F
Drugs Exp Clin Res; 1990; 16(1):39-48. PubMed ID: 2115831
[TBL] [Abstract][Full Text] [Related]
9. [6-methoxy-2-naphthylacetic acid level in plasma, synovial fluid and adjacent tissue in patients with rheumatoid arthritis or gonarthroses after a 4-day therapy with nabumetone (Arthaxan)].
Miehlke RK; Schneider S; Sörgel F; Muth P; Henschke F; Fedder M
Z Rheumatol; 1991; 50(2):103-8. PubMed ID: 1872041
[TBL] [Abstract][Full Text] [Related]
10. Leukotriene B4, a mediator of inflammation present in synovial fluid in rheumatoid arthritis.
Davidson EM; Rae SA; Smith MJ
Ann Rheum Dis; 1983 Dec; 42(6):677-9. PubMed ID: 6316858
[TBL] [Abstract][Full Text] [Related]
11. Questionable role of leukotriene B4 in monosodium urate (MSU)-induced synovitis in the dog.
Carlson RP; Chang J; Datko LJ; Lewis AJ
Prostaglandins; 1986 Oct; 32(4):579-85. PubMed ID: 3025938
[TBL] [Abstract][Full Text] [Related]
12. Relationship between leukotriene B4 and immunological parameters in rheumatoid synovial fluids.
Ahmadzadeh N; Shingu M; Nobunaga M; Tawara T
Inflammation; 1991 Dec; 15(6):497-503. PubMed ID: 1661709
[TBL] [Abstract][Full Text] [Related]
13. Synovial fluid and plasma kinetics of repeat dose sustained action tiaprofenic acid in patients with rheumatoid arthritis.
Nichol FE; Samanta A; Rose CM
Drugs; 1988; 35 Suppl 1():46-51. PubMed ID: 3359945
[TBL] [Abstract][Full Text] [Related]
14. The metabolism of synthetic leukotriene B4 in synovial fluid and whole human blood.
Forrest MJ; Burton D; Brooks PM
Prostaglandins; 1987 Sep; 34(3):433-43. PubMed ID: 2829280
[TBL] [Abstract][Full Text] [Related]
15. The contribution of synovial fluid lipoproteins to the chronic synovitis of rheumatoid arthritis.
Prete PE; Gurakar-Osborne A
Prostaglandins; 1997 Oct; 54(4):689-98. PubMed ID: 9440132
[TBL] [Abstract][Full Text] [Related]
16. Transsynovial kinetics of lonazolac and its hydroxy metabolite in synovitis patients.
Deneke J; Luckow V; Guserle R; Pässler HH
Int J Clin Pharmacol Ther; 1998 Aug; 36(8):418-24. PubMed ID: 9726694
[TBL] [Abstract][Full Text] [Related]
17. The synovial prostaglandin system in chronic inflammatory arthritis: differential effects of steroidal and nonsteroidal anti-inflammatory drugs.
Bombardieri S; Cattani P; Ciabattoni G; Di Munno O; Pasero G; Patrono C; Pinca E; Pugliese F
Br J Pharmacol; 1981 Aug; 73(4):893-901. PubMed ID: 6895043
[TBL] [Abstract][Full Text] [Related]
18. [Effect of sulfasalazine and its metabolites on prostaglandin and leukotriene liberation from human synovial tissue].
Wittenberg HR; Kleemeyer K; Peskar BM; Peskar BA
Wien Klin Wochenschr; 1991; 103(2):34-9. PubMed ID: 1673814
[TBL] [Abstract][Full Text] [Related]
19. Arachidonic acid metabolism in neutrophil granulocytes obtained from synovial fluid in rheumatoid arthritis.
Langholz E; Nielsen OH; Ahnfelt-Rønne I; Elmgreen J
Scand J Rheumatol; 1990; 19(6):387-91. PubMed ID: 2175453
[TBL] [Abstract][Full Text] [Related]
20. Antiinflammatory effect of tepoxalin: blood and synovial tissue studied in patients with knee arthrosis.
Willburger RE; Wittenberg RH; Schmidt K; Kleemeyer KS; Peskar BA
Acta Orthop Scand; 1998 Jun; 69(3):295-300. PubMed ID: 9703407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
